According to Collegium Pharmaceutical 's latest financial reports the company's current EPS (TTM) is -โน28.22. In 2022 the company made an earnings per share (EPS) of -โน63.28 a decrease over its 2021 EPS that were of โน171.88.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน27.25 | -56.95% |
2022 | -โน63.28 | -136.82% |
2021 | โน171.88 | 161.04% |
2020 | โน65.85 | -213.24% |
2019 | -โน58.15 | -43.33% |
2018 | -โน102.62 | -51.61% |
2017 | -โน212.07 | -36.08% |
2016 | -โน331.79 | 139.48% |
2015 | -โน138.55 | -42.94% |
2014 | -โน242.82 |